|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.52 SEK | -6.56% |
|
+21.05% | -18.05% |
| 06-23 | Citadel Back as Public Short Seller in Synact Pharma | FW |
| 06-18 | Edison Maintains Its Valuation for Synact Pharma After Trial Results | FW |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 21.05 | 24.2 | 24.95 |
| Spread/Res. | -12.02% | -23.47% | -25.77% |
| Spread/Supp. | +27.37% | +73.73% | +58.83% |
| Support | 14.54 | 10.66 | 11.66 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SYNACT Stock
- Charts SynAct Pharma AB
Select your edition
All financial news and data tailored to specific country editions
